Elfmark, Liv Anker http://orcid.org/0000-0002-7246-7270
Wenzel, Eva Maria http://orcid.org/0000-0002-5561-3344
Wang, Ling
Pedersen, Nina Marie
Stenmark, Harald http://orcid.org/0000-0002-1971-4252
Raiborg, Camilla http://orcid.org/0000-0002-5406-5403
Funding for this research was provided by:
Kreftforeningen (198140, 246670, 182698)
Helse Sør-Øst RHF (2018081)
European Research Council (788954)
Norges Forskningsråd (262652)
Trond Paulsen (InvaCell)
University of Oslo
Article History
Received: 23 March 2023
Revised: 6 July 2023
Accepted: 8 July 2023
First Online: 19 July 2023
Declarations
:
: The authors declare no competing financial interests.
: No ethics approval or consent was required since this study did not include patient samples, human subjects or animal experiments. We follow the ethics guide lines given by the University of Oslo.
: This study did not involve human subjects.All co-authors have seen and approved the final draft.